Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tissue Engineering | 51 | 2022 | 185 | 11.590 |
Why?
|
Blood Vessel Prosthesis | 49 | 2023 | 242 | 10.180 |
Why?
|
Tissue Scaffolds | 30 | 2022 | 111 | 6.540 |
Why?
|
Printing, Three-Dimensional | 15 | 2021 | 40 | 6.320 |
Why?
|
Blood Vessel Prosthesis Implantation | 24 | 2023 | 226 | 4.870 |
Why?
|
Cardiac Surgical Procedures | 26 | 2022 | 473 | 4.570 |
Why?
|
Heart Defects, Congenital | 24 | 2023 | 363 | 4.230 |
Why?
|
Bioprinting | 7 | 2020 | 13 | 3.890 |
Why?
|
Biocompatible Materials | 14 | 2022 | 198 | 3.160 |
Why?
|
Induced Pluripotent Stem Cells | 8 | 2021 | 115 | 3.000 |
Why?
|
Myocytes, Cardiac | 7 | 2024 | 313 | 2.750 |
Why?
|
Loeys-Dietz Syndrome | 7 | 2021 | 21 | 2.550 |
Why?
|
Spheroids, Cellular | 7 | 2020 | 31 | 2.400 |
Why?
|
Aortic Valve | 13 | 2023 | 243 | 2.380 |
Why?
|
Extracellular Matrix | 10 | 2022 | 244 | 2.370 |
Why?
|
Nanofibers | 5 | 2022 | 32 | 2.240 |
Why?
|
Aortic Valve Stenosis | 6 | 2023 | 143 | 2.050 |
Why?
|
Pulmonary Artery | 13 | 2022 | 318 | 1.980 |
Why?
|
Aortic Valve Insufficiency | 9 | 2021 | 131 | 1.910 |
Why?
|
Hypoplastic Left Heart Syndrome | 6 | 2024 | 77 | 1.860 |
Why?
|
Polyesters | 10 | 2020 | 41 | 1.810 |
Why?
|
Computer-Aided Design | 6 | 2020 | 17 | 1.740 |
Why?
|
Absorbable Implants | 7 | 2018 | 34 | 1.700 |
Why?
|
Fontan Procedure | 12 | 2022 | 56 | 1.690 |
Why?
|
Prosthesis Design | 12 | 2023 | 295 | 1.560 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2024 | 181 | 1.550 |
Why?
|
Bone Marrow Cells | 11 | 2017 | 262 | 1.540 |
Why?
|
Heart Valve Prosthesis | 4 | 2023 | 97 | 1.500 |
Why?
|
Ductus Arteriosus, Patent | 3 | 2022 | 40 | 1.470 |
Why?
|
Heart Transplantation | 6 | 2021 | 715 | 1.460 |
Why?
|
Coronary Vessel Anomalies | 2 | 2022 | 41 | 1.450 |
Why?
|
Heart Valve Prosthesis Implantation | 7 | 2023 | 178 | 1.400 |
Why?
|
Vena Cava, Inferior | 10 | 2016 | 145 | 1.390 |
Why?
|
Heart Ventricles | 10 | 2017 | 779 | 1.390 |
Why?
|
Myocardium | 6 | 2021 | 571 | 1.370 |
Why?
|
Vascular Grafting | 6 | 2020 | 16 | 1.340 |
Why?
|
Models, Anatomic | 4 | 2018 | 91 | 1.340 |
Why?
|
Coronary Vessels | 3 | 2022 | 190 | 1.320 |
Why?
|
Models, Cardiovascular | 7 | 2023 | 104 | 1.300 |
Why?
|
Vascular Surgical Procedures | 8 | 2021 | 149 | 1.300 |
Why?
|
Bioprosthesis | 7 | 2020 | 39 | 1.280 |
Why?
|
Infant | 24 | 2022 | 3130 | 1.240 |
Why?
|
Aneurysm, False | 3 | 2018 | 54 | 1.240 |
Why?
|
Humans | 132 | 2024 | 88835 | 1.240 |
Why?
|
Animals | 59 | 2024 | 27272 | 1.220 |
Why?
|
Pulmonary Valve | 4 | 2022 | 34 | 1.210 |
Why?
|
Nanotechnology | 2 | 2020 | 68 | 1.210 |
Why?
|
Regenerative Medicine | 2 | 2018 | 25 | 1.200 |
Why?
|
Polyglycolic Acid | 8 | 2022 | 9 | 1.190 |
Why?
|
Chitosan | 2 | 2018 | 18 | 1.180 |
Why?
|
Aortic Coarctation | 6 | 2023 | 36 | 1.130 |
Why?
|
Aorta | 10 | 2022 | 286 | 1.100 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2016 | 241 | 1.100 |
Why?
|
Double Outlet Right Ventricle | 3 | 2022 | 6 | 1.090 |
Why?
|
Blood Vessels | 7 | 2017 | 94 | 1.050 |
Why?
|
Aorta, Thoracic | 8 | 2023 | 166 | 1.020 |
Why?
|
Hypertension, Pulmonary | 3 | 2020 | 351 | 1.020 |
Why?
|
Fibroblasts | 4 | 2021 | 755 | 0.970 |
Why?
|
Postoperative Complications | 11 | 2020 | 2273 | 0.950 |
Why?
|
Mitral Valve | 6 | 2020 | 261 | 0.930 |
Why?
|
Pericardium | 5 | 2020 | 70 | 0.920 |
Why?
|
Regeneration | 3 | 2019 | 149 | 0.910 |
Why?
|
Tetralogy of Fallot | 2 | 2022 | 44 | 0.910 |
Why?
|
Hydrogels | 3 | 2022 | 86 | 0.900 |
Why?
|
Rats | 11 | 2024 | 4039 | 0.900 |
Why?
|
Neovascularization, Physiologic | 3 | 2020 | 142 | 0.900 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2022 | 18 | 0.860 |
Why?
|
Stress, Mechanical | 4 | 2021 | 253 | 0.810 |
Why?
|
Myocardial Contraction | 2 | 2021 | 252 | 0.810 |
Why?
|
Female | 63 | 2023 | 45893 | 0.810 |
Why?
|
Mitral Valve Insufficiency | 3 | 2020 | 192 | 0.800 |
Why?
|
Glycerol | 1 | 2022 | 34 | 0.800 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2021 | 89 | 0.790 |
Why?
|
Tacrolimus | 1 | 2022 | 369 | 0.770 |
Why?
|
Heart | 4 | 2024 | 573 | 0.760 |
Why?
|
Models, Animal | 10 | 2024 | 275 | 0.760 |
Why?
|
Coronary Occlusion | 1 | 2020 | 7 | 0.740 |
Why?
|
Respiratory Paralysis | 1 | 2020 | 8 | 0.740 |
Why?
|
Phrenic Nerve | 1 | 2020 | 42 | 0.730 |
Why?
|
Infant, Newborn | 15 | 2024 | 2464 | 0.730 |
Why?
|
Child | 30 | 2022 | 7112 | 0.730 |
Why?
|
Diaphragm | 1 | 2020 | 50 | 0.720 |
Why?
|
Reoperation | 12 | 2021 | 598 | 0.720 |
Why?
|
Hemodynamics | 12 | 2023 | 728 | 0.720 |
Why?
|
Imaging, Three-Dimensional | 5 | 2018 | 595 | 0.720 |
Why?
|
Heart Failure | 6 | 2019 | 1172 | 0.720 |
Why?
|
Graft Occlusion, Vascular | 4 | 2015 | 99 | 0.710 |
Why?
|
Mice | 29 | 2024 | 11722 | 0.700 |
Why?
|
Cells, Immobilized | 1 | 2019 | 2 | 0.700 |
Why?
|
Constriction, Pathologic | 6 | 2020 | 217 | 0.680 |
Why?
|
Aortic Aneurysm | 2 | 2018 | 80 | 0.670 |
Why?
|
Cardiopulmonary Bypass | 5 | 2019 | 157 | 0.670 |
Why?
|
Ultrasonic Therapy | 1 | 2019 | 34 | 0.670 |
Why?
|
Myocytes, Smooth Muscle | 4 | 2016 | 140 | 0.670 |
Why?
|
Leukocytes, Mononuclear | 4 | 2016 | 205 | 0.660 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2017 | 21 | 0.650 |
Why?
|
Treatment Outcome | 22 | 2023 | 8177 | 0.640 |
Why?
|
Surgery, Computer-Assisted | 3 | 2023 | 98 | 0.620 |
Why?
|
Heart Arrest | 2 | 2024 | 279 | 0.620 |
Why?
|
Coronary Aneurysm | 1 | 2018 | 16 | 0.620 |
Why?
|
Tunica Intima | 1 | 2018 | 60 | 0.610 |
Why?
|
Heart Septal Defects, Atrial | 4 | 2024 | 67 | 0.610 |
Why?
|
Stents | 2 | 2024 | 395 | 0.610 |
Why?
|
Time Factors | 16 | 2021 | 5311 | 0.610 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2018 | 50 | 0.600 |
Why?
|
Patient-Specific Modeling | 4 | 2023 | 20 | 0.600 |
Why?
|
Macrophages | 4 | 2016 | 570 | 0.590 |
Why?
|
Cells, Cultured | 12 | 2021 | 2879 | 0.590 |
Why?
|
Retrospective Studies | 22 | 2022 | 8960 | 0.570 |
Why?
|
Sheep | 7 | 2020 | 250 | 0.570 |
Why?
|
Human Umbilical Vein Endothelial Cells | 6 | 2021 | 68 | 0.560 |
Why?
|
Transplants | 2 | 2015 | 41 | 0.560 |
Why?
|
Child, Preschool | 21 | 2021 | 3695 | 0.560 |
Why?
|
Simulation Training | 1 | 2018 | 96 | 0.560 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2017 | 71 | 0.560 |
Why?
|
Polymers | 7 | 2019 | 194 | 0.550 |
Why?
|
Nanostructures | 1 | 2016 | 78 | 0.530 |
Why?
|
Tricuspid Valve Insufficiency | 4 | 2020 | 113 | 0.520 |
Why?
|
Cesarean Section | 1 | 2016 | 140 | 0.520 |
Why?
|
Heart Septal Defects, Ventricular | 6 | 2020 | 69 | 0.520 |
Why?
|
Male | 50 | 2024 | 42127 | 0.510 |
Why?
|
Rats, Inbred Lew | 3 | 2019 | 193 | 0.490 |
Why?
|
Prostheses and Implants | 1 | 2015 | 124 | 0.490 |
Why?
|
Computed Tomography Angiography | 4 | 2023 | 141 | 0.470 |
Why?
|
Bone Marrow Transplantation | 5 | 2011 | 283 | 0.460 |
Why?
|
Adaptive Immunity | 1 | 2015 | 167 | 0.450 |
Why?
|
Endothelial Cells | 5 | 2022 | 455 | 0.450 |
Why?
|
Adolescent | 16 | 2021 | 9201 | 0.440 |
Why?
|
Sinus of Valsalva | 2 | 2003 | 18 | 0.430 |
Why?
|
Mice, SCID | 8 | 2015 | 261 | 0.420 |
Why?
|
Guided Tissue Regeneration | 2 | 2011 | 7 | 0.410 |
Why?
|
Centrifugation, Density Gradient | 1 | 2011 | 112 | 0.390 |
Why?
|
Vascular Fistula | 2 | 2003 | 12 | 0.390 |
Why?
|
Filtration | 1 | 2011 | 25 | 0.390 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 1974 | 0.390 |
Why?
|
Immunity, Innate | 1 | 2015 | 428 | 0.380 |
Why?
|
Cell Differentiation | 7 | 2021 | 1521 | 0.380 |
Why?
|
Transplantation, Autologous | 7 | 2017 | 342 | 0.380 |
Why?
|
Rats, Nude | 3 | 2019 | 25 | 0.380 |
Why?
|
Cell Separation | 1 | 2011 | 198 | 0.380 |
Why?
|
Immunohistochemistry | 7 | 2017 | 1796 | 0.370 |
Why?
|
Endothelium, Vascular | 4 | 2019 | 433 | 0.370 |
Why?
|
MicroRNAs | 1 | 2015 | 550 | 0.370 |
Why?
|
Pulmonary Veins | 4 | 2012 | 93 | 0.370 |
Why?
|
Neointima | 2 | 2022 | 14 | 0.360 |
Why?
|
Disease Models, Animal | 7 | 2020 | 2347 | 0.360 |
Why?
|
Aneurysm | 2 | 2018 | 60 | 0.350 |
Why?
|
Databases, Factual | 4 | 2021 | 849 | 0.350 |
Why?
|
Intraoperative Care | 2 | 2020 | 84 | 0.350 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 805 | 0.340 |
Why?
|
Aortic Diseases | 2 | 2016 | 100 | 0.340 |
Why?
|
Mice, Inbred C57BL | 9 | 2017 | 3202 | 0.320 |
Why?
|
Forecasting | 3 | 2023 | 305 | 0.310 |
Why?
|
Blood Transfusion, Autologous | 1 | 2008 | 16 | 0.310 |
Why?
|
Echocardiography | 6 | 2024 | 936 | 0.310 |
Why?
|
Phlebotomy | 1 | 2008 | 21 | 0.310 |
Why?
|
Dogs | 6 | 2020 | 704 | 0.310 |
Why?
|
Truncus Arteriosus, Persistent | 2 | 2022 | 6 | 0.310 |
Why?
|
Blood Donors | 1 | 2008 | 22 | 0.300 |
Why?
|
Abnormalities, Multiple | 3 | 2008 | 234 | 0.300 |
Why?
|
Coronary Angiography | 2 | 2019 | 239 | 0.290 |
Why?
|
Electrocardiography | 2 | 2020 | 493 | 0.290 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 115 | 0.290 |
Why?
|
Tricuspid Valve | 3 | 2020 | 97 | 0.290 |
Why?
|
Follow-Up Studies | 9 | 2021 | 3649 | 0.280 |
Why?
|
Monocytes | 3 | 2015 | 216 | 0.270 |
Why?
|
Lactic Acid | 4 | 2012 | 92 | 0.270 |
Why?
|
Vascular Remodeling | 2 | 2016 | 22 | 0.270 |
Why?
|
Cell Proliferation | 5 | 2021 | 1649 | 0.260 |
Why?
|
Robotic Surgical Procedures | 3 | 2020 | 300 | 0.260 |
Why?
|
Cell Survival | 4 | 2019 | 981 | 0.260 |
Why?
|
Receptors, Transforming Growth Factor beta | 2 | 2016 | 45 | 0.260 |
Why?
|
Preoperative Care | 1 | 2008 | 395 | 0.260 |
Why?
|
Swine | 3 | 2024 | 581 | 0.250 |
Why?
|
Cytokines | 3 | 2020 | 801 | 0.250 |
Why?
|
Equipment Design | 2 | 2024 | 415 | 0.250 |
Why?
|
Vascular Patency | 3 | 2016 | 126 | 0.250 |
Why?
|
Cardiac Catheterization | 3 | 2020 | 301 | 0.240 |
Why?
|
Adult | 19 | 2022 | 26437 | 0.240 |
Why?
|
Silicon | 1 | 2024 | 18 | 0.230 |
Why?
|
Tensile Strength | 3 | 2020 | 80 | 0.230 |
Why?
|
Ligation | 3 | 2019 | 51 | 0.230 |
Why?
|
Heart Injuries | 1 | 2003 | 19 | 0.220 |
Why?
|
Tricuspid Atresia | 1 | 2022 | 4 | 0.220 |
Why?
|
Pacemaker, Artificial | 1 | 2024 | 94 | 0.220 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2024 | 68 | 0.220 |
Why?
|
Aortic Stenosis, Supravalvular | 2 | 2017 | 4 | 0.210 |
Why?
|
Sutures | 1 | 2022 | 53 | 0.210 |
Why?
|
Hyperplasia | 1 | 2022 | 152 | 0.210 |
Why?
|
Cell Line | 3 | 2019 | 2494 | 0.210 |
Why?
|
Mice, Transgenic | 4 | 2021 | 1573 | 0.210 |
Why?
|
Tissue Transplantation | 2 | 2017 | 12 | 0.210 |
Why?
|
Suture Techniques | 1 | 2023 | 140 | 0.200 |
Why?
|
Biomarkers | 3 | 2021 | 1751 | 0.200 |
Why?
|
Autografts | 2 | 2021 | 28 | 0.200 |
Why?
|
Colforsin | 1 | 2001 | 74 | 0.200 |
Why?
|
Polydioxanone | 1 | 2021 | 4 | 0.200 |
Why?
|
Biomedical Engineering | 1 | 2001 | 20 | 0.200 |
Why?
|
ABO Blood-Group System | 1 | 2021 | 58 | 0.190 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2003 | 136 | 0.190 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2001 | 36 | 0.190 |
Why?
|
Arteries | 2 | 2019 | 180 | 0.190 |
Why?
|
Balloon Valvuloplasty | 1 | 2021 | 8 | 0.190 |
Why?
|
Recovery of Function | 2 | 2020 | 292 | 0.190 |
Why?
|
Sarcomeres | 1 | 2021 | 27 | 0.190 |
Why?
|
Graft Survival | 3 | 2021 | 895 | 0.190 |
Why?
|
Vasodilator Agents | 1 | 2001 | 146 | 0.190 |
Why?
|
Milrinone | 1 | 2000 | 6 | 0.190 |
Why?
|
Ultrasonography, Prenatal | 2 | 2019 | 152 | 0.190 |
Why?
|
Feasibility Studies | 3 | 2019 | 778 | 0.190 |
Why?
|
Heart Atria | 3 | 2020 | 281 | 0.190 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 127 | 0.190 |
Why?
|
Cryopreservation | 1 | 2001 | 74 | 0.190 |
Why?
|
Receptors, Notch | 1 | 2021 | 123 | 0.190 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2000 | 30 | 0.180 |
Why?
|
Endoscopy | 2 | 2024 | 344 | 0.180 |
Why?
|
Atrial Natriuretic Factor | 1 | 2000 | 39 | 0.180 |
Why?
|
Exercise Tolerance | 1 | 2020 | 52 | 0.180 |
Why?
|
Cardiac Electrophysiology | 1 | 2020 | 7 | 0.180 |
Why?
|
Echocardiography, Transesophageal | 4 | 2021 | 346 | 0.180 |
Why?
|
Vena Cava, Superior | 3 | 2012 | 60 | 0.180 |
Why?
|
Ultrasonography | 3 | 2012 | 710 | 0.180 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 214 | 0.180 |
Why?
|
Burns, Inhalation | 1 | 2020 | 4 | 0.180 |
Why?
|
Risk Assessment | 4 | 2019 | 2285 | 0.180 |
Why?
|
Primary Graft Dysfunction | 1 | 2020 | 37 | 0.170 |
Why?
|
Angioplasty, Laser | 1 | 1999 | 1 | 0.170 |
Why?
|
Coculture Techniques | 1 | 2020 | 172 | 0.170 |
Why?
|
Angiography | 2 | 2015 | 208 | 0.170 |
Why?
|
Heart Aneurysm | 1 | 2019 | 22 | 0.170 |
Why?
|
Polypropylenes | 2 | 2020 | 23 | 0.170 |
Why?
|
Fumarates | 2 | 2020 | 19 | 0.170 |
Why?
|
Collagen | 2 | 2019 | 293 | 0.170 |
Why?
|
Myocardial Revascularization | 1 | 1999 | 29 | 0.170 |
Why?
|
Specimen Handling | 1 | 2020 | 102 | 0.170 |
Why?
|
Cell Size | 1 | 2019 | 67 | 0.170 |
Why?
|
Membranes, Artificial | 2 | 2010 | 39 | 0.170 |
Why?
|
Fetal Heart | 1 | 2018 | 13 | 0.160 |
Why?
|
Fistula | 1 | 1999 | 42 | 0.160 |
Why?
|
Intraoperative Complications | 1 | 2020 | 188 | 0.160 |
Why?
|
Hernias, Diaphragmatic, Congenital | 1 | 2018 | 14 | 0.160 |
Why?
|
Rabbits | 1 | 2020 | 637 | 0.160 |
Why?
|
Replantation | 1 | 2018 | 36 | 0.160 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 358 | 0.160 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2016 | 140 | 0.160 |
Why?
|
Proof of Concept Study | 1 | 2018 | 43 | 0.160 |
Why?
|
Infant, Extremely Low Birth Weight | 1 | 2018 | 26 | 0.160 |
Why?
|
Exosomes | 1 | 2019 | 53 | 0.160 |
Why?
|
In Vitro Techniques | 1 | 2020 | 996 | 0.160 |
Why?
|
Risk Factors | 5 | 2020 | 5447 | 0.150 |
Why?
|
Cell Culture Techniques | 5 | 2016 | 192 | 0.150 |
Why?
|
Artificial Organs | 1 | 2017 | 4 | 0.150 |
Why?
|
Goals | 1 | 2018 | 67 | 0.150 |
Why?
|
Hemorheology | 1 | 2017 | 8 | 0.150 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 161 | 0.150 |
Why?
|
Coronary Disease | 1 | 1999 | 260 | 0.150 |
Why?
|
Virtual Reality | 1 | 2018 | 24 | 0.150 |
Why?
|
Infant, Premature, Diseases | 1 | 2018 | 77 | 0.150 |
Why?
|
Ultrasonics | 1 | 2017 | 39 | 0.150 |
Why?
|
Lasers | 1 | 2017 | 107 | 0.150 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 125 | 0.150 |
Why?
|
Cardiovascular System | 1 | 2017 | 62 | 0.150 |
Why?
|
Transplantation, Homologous | 3 | 2019 | 991 | 0.150 |
Why?
|
Biomimetic Materials | 1 | 2017 | 23 | 0.150 |
Why?
|
Electrophysiological Phenomena | 1 | 2017 | 51 | 0.140 |
Why?
|
Nervous System | 1 | 2017 | 89 | 0.140 |
Why?
|
Sheep, Domestic | 1 | 2016 | 9 | 0.140 |
Why?
|
Venous Pressure | 1 | 2016 | 11 | 0.140 |
Why?
|
Registries | 1 | 2021 | 770 | 0.140 |
Why?
|
Hydrodynamics | 3 | 2023 | 19 | 0.140 |
Why?
|
Liver | 2 | 2021 | 1204 | 0.140 |
Why?
|
Phlebography | 1 | 2016 | 66 | 0.140 |
Why?
|
Mitral Valve Annuloplasty | 1 | 2016 | 16 | 0.140 |
Why?
|
Cell-Free System | 1 | 2016 | 51 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 2647 | 0.140 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2017 | 61 | 0.140 |
Why?
|
Lung Diseases | 1 | 2019 | 269 | 0.140 |
Why?
|
Bioreactors | 1 | 2016 | 11 | 0.140 |
Why?
|
Heart Diseases | 1 | 1999 | 298 | 0.140 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2016 | 59 | 0.140 |
Why?
|
Endothelial Progenitor Cells | 1 | 2016 | 13 | 0.140 |
Why?
|
Cardiology | 1 | 2017 | 114 | 0.140 |
Why?
|
Dyspnea | 1 | 2016 | 75 | 0.140 |
Why?
|
Bone and Bones | 1 | 2017 | 269 | 0.130 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 328 | 0.130 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2016 | 59 | 0.130 |
Why?
|
Diverticulum | 1 | 2016 | 45 | 0.130 |
Why?
|
Pregnancy | 3 | 2019 | 3002 | 0.130 |
Why?
|
Incidence | 1 | 2020 | 1591 | 0.130 |
Why?
|
Connective Tissue Diseases | 1 | 2016 | 69 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 115 | 0.130 |
Why?
|
Shock, Cardiogenic | 1 | 2016 | 105 | 0.130 |
Why?
|
Gestational Age | 1 | 2016 | 323 | 0.130 |
Why?
|
Graft Rejection | 1 | 2021 | 1061 | 0.130 |
Why?
|
Tetrazoles | 1 | 2015 | 24 | 0.130 |
Why?
|
Surgeons | 1 | 2020 | 247 | 0.130 |
Why?
|
Severity of Illness Index | 2 | 2018 | 1835 | 0.130 |
Why?
|
Dioxoles | 1 | 2015 | 7 | 0.130 |
Why?
|
Wound Healing | 1 | 2017 | 359 | 0.130 |
Why?
|
Adipose Tissue | 1 | 2017 | 259 | 0.130 |
Why?
|
Coated Materials, Biocompatible | 1 | 2015 | 30 | 0.120 |
Why?
|
Lung Transplantation | 1 | 2019 | 282 | 0.120 |
Why?
|
Patient Selection | 1 | 2018 | 681 | 0.120 |
Why?
|
Thrombosis | 1 | 2017 | 302 | 0.120 |
Why?
|
Antigens, Differentiation | 1 | 2015 | 141 | 0.120 |
Why?
|
Blood Platelets | 1 | 2015 | 150 | 0.120 |
Why?
|
Trachea | 1 | 2015 | 291 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 465 | 0.120 |
Why?
|
Inflammation Mediators | 1 | 2015 | 153 | 0.120 |
Why?
|
Ilizarov Technique | 1 | 2013 | 1 | 0.120 |
Why?
|
Finger Joint | 1 | 2013 | 14 | 0.120 |
Why?
|
Skin | 1 | 2017 | 581 | 0.120 |
Why?
|
Software | 1 | 2018 | 665 | 0.120 |
Why?
|
Heparin | 1 | 2015 | 185 | 0.120 |
Why?
|
Immune System | 1 | 2015 | 97 | 0.120 |
Why?
|
Pulmonary Circulation | 2 | 2017 | 90 | 0.120 |
Why?
|
Contracture | 1 | 2013 | 18 | 0.120 |
Why?
|
Benzamides | 1 | 2015 | 237 | 0.120 |
Why?
|
Inflammation | 2 | 2017 | 969 | 0.110 |
Why?
|
Societies, Medical | 1 | 2017 | 566 | 0.110 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2013 | 13 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 275 | 0.110 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 2 | 2003 | 9 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 887 | 0.110 |
Why?
|
Coronary Artery Bypass | 2 | 2006 | 233 | 0.110 |
Why?
|
Liver Transplantation | 1 | 2020 | 1175 | 0.110 |
Why?
|
Metacarpal Bones | 1 | 2012 | 12 | 0.110 |
Why?
|
Catheterization | 1 | 2014 | 237 | 0.100 |
Why?
|
Body Weight | 1 | 2014 | 452 | 0.100 |
Why?
|
Lung | 1 | 2019 | 1253 | 0.100 |
Why?
|
Y Chromosome | 1 | 2012 | 29 | 0.100 |
Why?
|
Young Adult | 3 | 2020 | 6271 | 0.100 |
Why?
|
Caproates | 2 | 2016 | 5 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 3441 | 0.100 |
Why?
|
Paracrine Communication | 1 | 2012 | 32 | 0.100 |
Why?
|
United States | 3 | 2020 | 6928 | 0.100 |
Why?
|
Lactones | 2 | 2016 | 27 | 0.100 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 39 | 0.100 |
Why?
|
Heart-Assist Devices | 1 | 2018 | 752 | 0.100 |
Why?
|
Random Allocation | 2 | 2016 | 328 | 0.090 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 354 | 0.090 |
Why?
|
Survival Rate | 3 | 2021 | 1880 | 0.090 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 282 | 0.090 |
Why?
|
Fibrin | 2 | 2022 | 86 | 0.090 |
Why?
|
Signal Transduction | 1 | 2021 | 3370 | 0.090 |
Why?
|
Gene Expression | 1 | 2015 | 1309 | 0.090 |
Why?
|
Cell Transplantation | 1 | 2010 | 47 | 0.090 |
Why?
|
Blood Flow Velocity | 2 | 2021 | 198 | 0.090 |
Why?
|
Venae Cavae | 1 | 2010 | 13 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2015 | 738 | 0.090 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 2 | 2010 | 46 | 0.090 |
Why?
|
Workflow | 2 | 2022 | 80 | 0.090 |
Why?
|
Ductus Arteriosus | 1 | 2009 | 27 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2011 | 690 | 0.080 |
Why?
|
Interferon-gamma | 1 | 2011 | 451 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 321 | 0.080 |
Why?
|
Stem Cells | 2 | 2023 | 372 | 0.080 |
Why?
|
Pulmonary Atresia | 1 | 2008 | 12 | 0.080 |
Why?
|
Collateral Circulation | 1 | 2008 | 35 | 0.080 |
Why?
|
T-Lymphocytes | 1 | 2015 | 1222 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2011 | 442 | 0.080 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 74 | 0.080 |
Why?
|
Tissue Adhesions | 1 | 2008 | 49 | 0.080 |
Why?
|
Coronary Circulation | 1 | 2008 | 131 | 0.080 |
Why?
|
Prospective Studies | 4 | 2019 | 4255 | 0.080 |
Why?
|
Hyaluronic Acid | 1 | 2008 | 49 | 0.080 |
Why?
|
Hemoglobins | 1 | 2008 | 192 | 0.070 |
Why?
|
Heart Valves | 1 | 2006 | 24 | 0.070 |
Why?
|
Blood Pressure | 2 | 2020 | 898 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 847 | 0.070 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2005 | 15 | 0.070 |
Why?
|
Magnesium | 1 | 2006 | 178 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2019 | 858 | 0.060 |
Why?
|
Hydroxyproline | 1 | 2005 | 11 | 0.060 |
Why?
|
Collagen Type IV | 1 | 2005 | 26 | 0.060 |
Why?
|
Apoptosis | 1 | 2012 | 1715 | 0.060 |
Why?
|
Femoral Vein | 1 | 2005 | 39 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 1712 | 0.060 |
Why?
|
Cardiac Volume | 1 | 2005 | 53 | 0.060 |
Why?
|
Survival Analysis | 2 | 2018 | 1533 | 0.060 |
Why?
|
Microscopy, Electron | 1 | 2005 | 510 | 0.060 |
Why?
|
Ventricular Function, Right | 1 | 2005 | 146 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 704 | 0.060 |
Why?
|
Semiconductors | 1 | 2024 | 11 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2005 | 118 | 0.060 |
Why?
|
Norwood Procedures | 1 | 2024 | 40 | 0.060 |
Why?
|
Heart Bypass, Right | 1 | 2003 | 12 | 0.060 |
Why?
|
Prevalence | 2 | 2018 | 1238 | 0.060 |
Why?
|
Vacuum | 2 | 2015 | 10 | 0.060 |
Why?
|
Surgical Flaps | 1 | 2006 | 249 | 0.060 |
Why?
|
Aortography | 1 | 2023 | 65 | 0.060 |
Why?
|
Resuscitation | 1 | 2024 | 109 | 0.060 |
Why?
|
Middle Aged | 9 | 2013 | 25783 | 0.060 |
Why?
|
Saphenous Vein | 1 | 2003 | 61 | 0.060 |
Why?
|
Hepatic Veins | 1 | 2003 | 26 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2008 | 1849 | 0.050 |
Why?
|
Wounds, Penetrating | 1 | 2003 | 56 | 0.050 |
Why?
|
Heart Arrest, Induced | 1 | 2002 | 30 | 0.050 |
Why?
|
Perfusion | 2 | 2016 | 234 | 0.050 |
Why?
|
Postoperative Period | 2 | 2019 | 301 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2024 | 161 | 0.050 |
Why?
|
Injury Severity Score | 1 | 2003 | 139 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2022 | 30 | 0.050 |
Why?
|
Uncertainty | 1 | 2022 | 74 | 0.050 |
Why?
|
Suicide, Attempted | 1 | 2003 | 133 | 0.050 |
Why?
|
Homeobox Protein Nkx-2.5 | 1 | 2021 | 13 | 0.050 |
Why?
|
Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2021 | 8 | 0.050 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2024 | 250 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2006 | 349 | 0.050 |
Why?
|
GATA4 Transcription Factor | 1 | 2021 | 19 | 0.050 |
Why?
|
Mouse Embryonic Stem Cells | 1 | 2021 | 11 | 0.050 |
Why?
|
Anastomosis, Surgical | 1 | 2003 | 273 | 0.050 |
Why?
|
Hydroxyethyl Starch Derivatives | 1 | 2001 | 6 | 0.050 |
Why?
|
Organ Preservation Solutions | 1 | 2001 | 28 | 0.050 |
Why?
|
Carotid Arteries | 1 | 2022 | 127 | 0.050 |
Why?
|
Adenylyl Cyclases | 1 | 2001 | 100 | 0.050 |
Why?
|
Dimethyl Sulfoxide | 1 | 2001 | 38 | 0.050 |
Why?
|
Clinical Decision-Making | 1 | 2023 | 279 | 0.050 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2000 | 3 | 0.050 |
Why?
|
Cell Adhesion | 2 | 2013 | 425 | 0.050 |
Why?
|
3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2000 | 8 | 0.050 |
Why?
|
Pilot Projects | 2 | 2017 | 865 | 0.050 |
Why?
|
Mesoderm | 1 | 2021 | 124 | 0.050 |
Why?
|
Water | 1 | 2022 | 283 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2005 | 602 | 0.050 |
Why?
|
Tissue and Organ Procurement | 1 | 2005 | 343 | 0.050 |
Why?
|
Urination | 1 | 2000 | 37 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 312 | 0.050 |
Why?
|
Calcium | 1 | 2005 | 1171 | 0.040 |
Why?
|
Biomimetics | 1 | 2020 | 31 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 2021 | 124 | 0.040 |
Why?
|
Intuition | 1 | 2020 | 8 | 0.040 |
Why?
|
Prosthesis Failure | 2 | 2015 | 115 | 0.040 |
Why?
|
Cattle | 1 | 2020 | 375 | 0.040 |
Why?
|
Acute Disease | 1 | 2001 | 837 | 0.040 |
Why?
|
Illinois | 1 | 2021 | 472 | 0.040 |
Why?
|
Treatment Failure | 1 | 2020 | 287 | 0.040 |
Why?
|
Aged | 5 | 2005 | 19014 | 0.040 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 130 | 0.040 |
Why?
|
Stromal Cells | 1 | 2020 | 151 | 0.040 |
Why?
|
Allografts | 1 | 2020 | 178 | 0.040 |
Why?
|
DNA | 1 | 2005 | 1307 | 0.040 |
Why?
|
Infusion Pumps | 1 | 2019 | 25 | 0.040 |
Why?
|
Cardioplegic Solutions | 1 | 2019 | 17 | 0.040 |
Why?
|
Anticoagulants | 1 | 2022 | 425 | 0.040 |
Why?
|
Regional Blood Flow | 1 | 2019 | 198 | 0.040 |
Why?
|
Adipocytes | 1 | 2020 | 162 | 0.040 |
Why?
|
Marfan Syndrome | 1 | 2018 | 28 | 0.040 |
Why?
|
Surface Properties | 1 | 2019 | 131 | 0.040 |
Why?
|
Patient Compliance | 1 | 2020 | 230 | 0.040 |
Why?
|
Infant Mortality | 1 | 2018 | 59 | 0.040 |
Why?
|
Radiography | 2 | 2012 | 809 | 0.040 |
Why?
|
Albumins | 1 | 2019 | 129 | 0.040 |
Why?
|
North America | 1 | 2018 | 183 | 0.040 |
Why?
|
Organ Size | 1 | 2019 | 368 | 0.040 |
Why?
|
Heart Rate | 1 | 2000 | 493 | 0.040 |
Why?
|
Drainage | 1 | 2019 | 159 | 0.040 |
Why?
|
Computer Simulation | 1 | 2022 | 1096 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 306 | 0.040 |
Why?
|
Waiting Lists | 1 | 2018 | 182 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 555 | 0.040 |
Why?
|
Propensity Score | 1 | 2018 | 146 | 0.040 |
Why?
|
Injections | 1 | 2017 | 115 | 0.040 |
Why?
|
Foramen Ovale, Patent | 1 | 2017 | 18 | 0.040 |
Why?
|
Echocardiography, Doppler | 1 | 2018 | 186 | 0.040 |
Why?
|
Actinin | 1 | 2016 | 19 | 0.040 |
Why?
|
Europe | 1 | 2017 | 319 | 0.040 |
Why?
|
Rewarming | 1 | 2016 | 5 | 0.030 |
Why?
|
Circulatory Arrest, Deep Hypothermia Induced | 1 | 2016 | 5 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2021 | 1990 | 0.030 |
Why?
|
Sternotomy | 1 | 2016 | 22 | 0.030 |
Why?
|
Health Status | 1 | 2018 | 370 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2022 | 2750 | 0.030 |
Why?
|
Infant, Premature | 1 | 2018 | 295 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2017 | 161 | 0.030 |
Why?
|
Hospital Mortality | 1 | 2018 | 386 | 0.030 |
Why?
|
Prognosis | 1 | 2003 | 3756 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 271 | 0.030 |
Why?
|
Length of Stay | 1 | 2018 | 732 | 0.030 |
Why?
|
Compressive Strength | 1 | 2014 | 24 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2014 | 36 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 2014 | 46 | 0.030 |
Why?
|
Materials Testing | 1 | 2014 | 93 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 89 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2015 | 158 | 0.030 |
Why?
|
Logistic Models | 1 | 2018 | 1209 | 0.030 |
Why?
|
Aspirin | 1 | 2015 | 159 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 143 | 0.030 |
Why?
|
External Fixators | 1 | 2013 | 19 | 0.030 |
Why?
|
Tissue and Organ Harvesting | 1 | 2014 | 78 | 0.030 |
Why?
|
Age Factors | 1 | 2018 | 1862 | 0.030 |
Why?
|
Transcription Factors | 1 | 2021 | 1650 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2013 | 154 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 420 | 0.030 |
Why?
|
Osteonecrosis | 1 | 2012 | 22 | 0.030 |
Why?
|
Ribs | 1 | 2012 | 46 | 0.030 |
Why?
|
Elastin | 1 | 2011 | 8 | 0.030 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 29 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 1236 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2011 | 27 | 0.020 |
Why?
|
Arteriosclerosis | 1 | 2011 | 112 | 0.020 |
Why?
|
Cohort Studies | 1 | 2018 | 2853 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 199 | 0.020 |
Why?
|
Th17 Cells | 1 | 2011 | 84 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 47 | 0.020 |
Why?
|
Cyanosis | 1 | 2009 | 9 | 0.020 |
Why?
|
Heart Murmurs | 1 | 2009 | 6 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 275 | 0.020 |
Why?
|
Thoracotomy | 1 | 2009 | 63 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 370 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2008 | 122 | 0.020 |
Why?
|
Spleen | 1 | 2008 | 431 | 0.020 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2005 | 12 | 0.020 |
Why?
|
Hypertrophy | 1 | 2005 | 67 | 0.020 |
Why?
|
Epistaxis | 1 | 2005 | 19 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 262 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 478 | 0.010 |
Why?
|
Postoperative Care | 1 | 2005 | 228 | 0.010 |
Why?
|
Rheumatic Heart Disease | 1 | 2003 | 30 | 0.010 |
Why?
|
Mitral Valve Stenosis | 1 | 2003 | 38 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 1763 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 2002 | 43 | 0.010 |
Why?
|